Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 394
Selected: 0
NCT IDTitle
NCT02767362A Pre-Op Window Study Evaluating Anti-Proliferative Effects of Atorvastatin on the Endometrium
NCT01956253Single Subject Neratinib in Bladder Cancer (NRR)
NCT06306924UNC Metastatic Cancer Radiation Therapy Registry
NCT01208662Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatment With SCT in MM Patients up to Age 65
NCT05630131ctDNA in Subjects With Muscle-invasive Bladder Cancer Treated With Trimodality Therapy
NCT06814795Medically Tailored Meals for Kids
NCT03176082Mailed Reminders Plus Fecal Immunochemical Testing
NCT02682836Physical Activity to Maintain Quality of Life and Physical Function in Women With Metastatic Breast Cancer: a Pilot Study
NCT03785782ARFI, VisR and DDAI Ultrasound for Improving Discrimination of Malignant and Unresponsive Breast Cancer
NCT03672318Study of ATLCAR.CD138 Cells for Relapsed/Refractory Multiple Myeloma
NCT02035787Metformin With the Levonorgestrel-Releasing Intrauterine Device for the Treatment of Complex Atypical Hyperplasia (CAH) and Endometrial Cancer (EC) in Non-surgical Patients
NCT01752751Predicting Tolerance to Radiation Therapy in Older Adults With Cancer
NCT01204450Temsirolimus and Valproic Acid in Treating Young Patients With Relapsed Neuroblastoma, Bone Sarcoma, or Soft Tissue Sarcoma
NCT06896162PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival
NCT01578954Lenalidomide as Consolidation and Maintenance in Adults >/= 60 Years of Age With AML Following Standard Induction
NCT03386383mHealth Physical Activity Intervention for Survivors of Adolescent and Young Adult Cancers
NCT01612351Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery
NCT03978624Window of Opportunity Study of Pembrolizumab Alone and in Combinations in Bladder Cancer
NCT03263442High Dose Intravenous Thiamine for the Prevention of Delirium in Allogeneic Hematopoietic Stem Cell Transplantation
NCT00767468Sorafenib in Treating Patients With Locally Advanced or Metastatic Liver Cancer and Cirrhosis
NCT05714982Impact of E-cigarette Device Warnings
NCT06096623The Care Tracker Study: Using Patient-Reported Data to Address Racial Disparity in Cancer Treatment
NCT00225420Docetaxel, Androgen Ablation, and External-Beam Radiation Therapy in Patients With High-Risk Localized Prostate Cancer
NCT03819569GRADE-SRM: Genomic Risk Assessment and Decisional Evaluation for Small Renal Masses
NCT041369123-D Super Resolution Ultrasound Microvascular Imaging
NCT06618300Streamlined Resin Y90 Radiation Segmentectomy for Small HCC
NCT01560663Predictors of Response to Neoadjuvant Docetaxel-Carboplatin Chemotherapy for Patients With Stage II and III Triple Negative Breast Cancer
NCT02700022A Phase I Study of Alisertib + R-EPOCH for Treatment of Myc-Positive Aggressive B-cell Lymphomas
NCT06090864ATLCAR.CD30.CCR4 for CD30+ HL ATLCAR.CD30.CCR4 Cells
NCT00577694Clofarabine and Gemtuzumab in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
NCT00380029Erlotinib Before and After Surgery in Treating Patients With Muscle-Invasive Bladder Cancer
NCT04570709RN-Led Palliative and Supportive Care Intervention
NCT04644419Chemotherapy-related Cognitive Impairment and Acute Leukemia
NCT06348147Dara-RVd Induction for Newly Diagnosed Multiple Myeloma With Autologous Stem Cell Transplantation
NCT00123929Genetic Expression and Prediction of Response to Neoadjuvant Docetaxel or Doxorubicin in Locally Advanced Breast Cancer
NCT01492881Study of Vorinostat With Doxil and Bortezomib for Patients With Relapsed/Refractory Multiple Myeloma
NCT00519831Ph II of Vinflunine and Cetuximab in Second Line Treatment of NSCLC
NCT02138617Genotype-Directed Study Of Irinotecan Dosing In FOLFIRI + BevacizumabTreated Metastatic Colorectal Cancer
NCT00006110Multimodality Treatment for Women With Stage II, Stage III, or Stage IV Breast Cancer
NCT02111616Improving Survivorship Care Through Enhanced Communication and Coordination: Pilot Study
NCT00099008Genistein in Preventing Breast or Endometrial Cancer in Healthy Postmenopausal Women
NCT04978350Overcoming Barriers to the Uptake of Cascade Screening for Lynch Syndrome: Workbook Feasibility Study
NCT04342260Improving Quality of Life After Thoracic Surgery Using Patient-Reported Outcomes
NCT07116837Perceived Effectiveness of Vaping Prevention Ads Among Adolescents and Young Adults
NCT01305954Study of the P16 Gene as a Predictor of Myelosuppression in Breast Cancer Patients
NCT03407430Trial of Pregabalin for Granulocyte Colony-stimulating Factor (GCSF)-Induced Bone Pain
NCT06441487mPATH-Cloud for Colorectal Cancer Screening
NCT01488487Everolimus and Pasireotide (SOM230) in Patients With Advanced or Metastatic Hepatocellular Carcinoma
NCT02276560Cisplatin and Nab-paclitaxel for (N2) Defined NSCLC
NCT06296368DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics